Effects of Cinacalcet on Atherosclerotic and Nonatherosclerotic Cardiovascular Events in Patients Receiving Hemodialysis: The EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events (EVOLVE) Trial

BACKGROUND: Premature cardiovascular disease limits the duration and quality of life on long‐term hemodialysis. The objective of this study was to define the frequency of fatal and nonfatal cardiovascular events attributable to atherosclerotic and nonatherosclerotic mechanisms, risk factors for thes...

Descripción completa

Detalles Bibliográficos
Autores principales: Wheeler, David C., London, Gerard M., Parfrey, Patrick S., Block, Geoffrey A., Correa‐Rotter, Ricardo, Dehmel, Bastian, Drüeke, Tilman B., Floege, Jürgen, Kubo, Yumi, Mahaffey, Kenneth W., Goodman, William G., Moe, Sharon M., Trotman, Marie‐Louise, Abdalla, Safa, Chertow, Glenn M., Herzog, Charles A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4338730/
https://www.ncbi.nlm.nih.gov/pubmed/25404192
http://dx.doi.org/10.1161/JAHA.114.001363

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4338730/
https://www.ncbi.nlm.nih.gov/pubmed/25404192
http://dx.doi.org/10.1161/JAHA.114.001363

Ejemplares similares